Former Chief Executive Officer (4) · Armata Pharmaceuticals, Inc. (ARMP)

Todd Patrick

A named executive officer of Armata Pharmaceuticals in every fiscal year CompBrief holds from FY2018 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,379,569

Salary $566,500Stock awards $0

FY2020: $826,754

2nd of 3 named executive officers at Armata Pharmaceuticals by FY2021 total.

3 named officers on file for Armata Pharmaceuticals, FY2021

Todd Patrick’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Armata Pharmaceuticals’s whole pay program stands against its peers

  • Armata Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ARMP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 17, 2022 (DEF 14A).

Free

Get Todd Patrick’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Todd Patrick compensation by year

Armata Pharmaceuticals Summary Compensation Table · all 4 fiscal years held
In US dollars, as Armata Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021
Salary$412,000$412,000$515,500$566,500
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$0$714,556$53,504$529,819
Non-equity incentive$206,000$144,200$257,750$283,250
Pension and deferred compensation$0$0$0$0
All other$0$0$0$0
Total$618,000$1,270,756$826,754$1,379,569

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Armata Pharmaceuticals, Inc. DEF 14A filed October 17, 2022, accession 0001104659-22-109383, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Armata Pharmaceuticals, Inc. filed document, accession 0001104659-22-109383. Every figure is read from that document and cited to the page and table it appears in. Filed October 17, 2022.

$618K
$1.3M
$827K
$1.4M
FY18
FY19
FY20
FY21
SalaryNon-equity incentiveOption awards

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option112,021—$3.15
Option11,500—$3.15
Option70,000—$5.14

Per the Outstanding Equity Awards at Fiscal Year-End table in Armata Pharmaceuticals, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Armata Pharmaceuticals’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Brian VarnumChief Executive Officer$1,475,935
Todd Patrick · this pageFormer Chief Executive Officer (4)$1,379,569
Steve MartinFormer Chief Financial Officer (4)$654,805

Board service

Armata Pharmaceuticals board · FY2022
Director compensation in US dollars, as Armata Pharmaceuticals reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2022$38,300—$121,111$0$159,411

Each year as the company reported it in Armata Pharmaceuticals's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Armata Pharmaceuticals pays directors a $40,000 cash retainer. As stated in Armata Pharmaceuticals's FY2022 proxy.

The full Armata Pharmaceuticals compensation record

free company brief

This page is one person within Armata Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Armata Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Todd Patrick's compensation dossier · One-time report. No refunds.